When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
IRWD - Cyclerion Therapeutics: Distressed Spinoff Developing New Medicines For CNS Disorders
Ironwood Pharmaceuticals Inc.
Cyclerion is a spinoff from Ironwood Pharmaceuticals that has had 2 clinical failures but has a unique lead asset in neurodegeneration.
Cyclerion has upcoming phase 2 data coming out in H12022 that will be a major inflection point to potentially open up new opportunities for the distressed company.
As a result, the company is one to monitor over the next few months and wait to potentially buy the stock after new clinical data is reported.